References
Key articles
Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992 Aug 6;327(6):380-4. Abstract
Simons FE, Ardusso LR, Bilò MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):389-99. Abstract
National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. December 2011 [internet publication].Full text
Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis: a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84. Abstract
Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008 Mar;100(3 suppl 3):S1-148. Abstract
National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
Dinakar, C. Anaphylaxis in children: current understanding and key issues in diagnosis and treatment. Curr Allergy Asthma Rep. 2012 Dec;12(6):641-9.Full text Abstract
Sheikh A, Shehata YA, Brown SG, et al. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009 Feb;64(2):204-12.Full text Abstract
Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD008838.Full text Abstract
Wang J, Sampson HA. Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res. 2009 Oct;1(1):19-29.Full text Abstract
Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis: a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341-384. Abstract
Reference articles
1. LoVerde D, Iweala OI, Eginli A, et al. Anaphylaxis. Chest. 2017 Aug 8;153(2):528-43.Full text Abstract
2. World Allergy Organization Allergic Diseases Resource Center. Anaphylaxis. April 2019 [internet publication].
3. DesRoches A, Infante-Rivard C, Paradis L, et al. Peanut allergy: is maternal transmission of antigens during pregnancy and breastfeeding a risk factor? J Investig Allergol Clin Immunol. 2010;20(4):289-94. Abstract
4. Pitt TJ, Becker AB, Chan-Yeung M, et al. Reduced risk of peanut sensitization following exposure through breast-feeding and early peanut introduction. J Allergy Clin Immunol. 2017 Sep 12;141(2):620-5.e1.Full text Abstract
5. Järvinen KM, Westfall J, De Jesus M, et al. Role of maternal dietary peanut exposure in development of food allergy and oral tolerance. PLoS One. 2015 Dec 10;10(12):e0143855.Full text Abstract
6. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report - second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006 Feb;117(2):391-7.Full text Abstract
7. Campbell RL, Hagan JB, Manivannan V, et al. Evaluation of National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol. 2012 Mar;129(3):748-52. Abstract
8. Lieberman P, Camargo CA Jr, Bohlke K, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol. 2006 Nov;97(5):596-602. Abstract
9. Wood RA, Camargo CA Jr, Lieberman P, et al. Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States. J Allergy Clin Immunol. 2014 Feb;133(2):461-7.Full text Abstract
10. Grabenhenrich LB, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol. 2016 Apr;137(4):1128-37;e1.Full text Abstract
11. Lee S, Hess EP, Lohse C, et al. Trends, characteristics, and incidence of anaphylaxis in 2001-2010: a population-based study. J Allergy Clin Immunol. 2017 Jan;139(1):182-8;e2.Full text Abstract
12. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis - a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol. 2020 Apr;145(4):1082-123.Full text Abstract
13. Umasunthar T, Leonardi-Bee J, Turner PJ, et al. Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis. Clin Exp Allergy. 2015 Nov;45(11):1621-36. Abstract
14. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001 Jan;107(1):191-3. Abstract
15. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. J Emerg Med. 2005 May;28(4):381-8. Abstract
16. Brown AF, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. J Allergy Clin Immunol. 2001 Nov;108(5):861-6. Abstract
17. Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003 Jun;111(6 Pt 3):1601-8.Full text Abstract
18. Sue MA, Noritake DT, Klaustermeyer WB. Penicillin anaphylaxis: fatality in elderly patients without a history of penicillin allergy. Am J Emerg Med. 1988 Sep;6(5):456-8. Abstract
19. Worm M. Epidemiology of anaphylaxis. Chem Immunol Allergy. 2010 Jun 1;95:12-21. Abstract
20. Gelincik A, Demirtürk M, Yılmaz E, et al. Anaphylaxis in a tertiary adult allergy clinic: a retrospective review of 516 patients. Ann Allergy Asthma Immunol. 2012 Dec 20;110(2):96-100. Abstract
21. Aun MV, Blanca M, Garro LS, et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014 May 23;2(4):414-20. Abstract
22. McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2015 Oct 6;137(3):868-78.Full text Abstract
23. Castells MC, Horan RF, Sheffer AL. Exercise-induced anaphylaxis. Curr Allergy Asthma Rep. 2003 Jan;3(1):15-21. Abstract
24. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992 Aug 6;327(6):380-4. Abstract
25. Chung CH, Mirakhur B, Chan E, et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med. 2008 Mar 13;358(11):1109-17.Full text Abstract
26. Valentine MD. Anaphylaxis and stinging insect hypersensitivity. JAMA. 1992 Nov 25;268(20):2830-3. Abstract
27. Ewan PW, Dugué P, Mirakian R, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010 Jan;40(1):15-31.Full text Abstract
28. Royal College of Anaesthetists. Anaesthesia, surgery and life-threatening allergic reactions. Report and findings of the Royal College of Anaesthetists’ 6th National Audit Project: perioperative anaphylaxis. May 2018 [internet publication].Full text
29. Dewachter P, Mouton-Faivre C. Allergic risk during paediatric anaesthesia [in French]. Ann Fr Anesth Reanim. 2010 Mar;29(3):215-26. Abstract
30. De Weck AL, Sanz ML, Gamboa PM, et al. Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. J Investig Allergol Clin Immunol. 2010;20(1):39-57.Full text Abstract
31. Verrill L, Bruns R, Luccioli S. Prevalence of self reported food allergy in US adults: 2001, 2006, and 2010. Allergy Asthma Proc. 2015 Oct 8. Abstract
32. Kool B, Chandra D, Fitzharris P. Adult food-induced anaphylaxis hospital presentations in New Zealand. Postgrad Med J. 2016 Apr 6;92(1093):640-4. Abstract
33. Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol. 2014 Nov 25;135(4):956-63.e1.Full text Abstract
34. Jerschow E, Lin RY, Scaperotti MM, et al. Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations. J Allergy Clin Immunol. 2014 Sep 30;134(6):1318-28.e7.Full text Abstract
35. Santos AF, Lack G. Food allergy and anaphylaxis in pediatrics: update 2010-2012. Pediatr Allergy Immunol. 2012 Dec;23(8):698-706. Abstract
36. Summers CW, Pumphrey RS, Woods CN, et al. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol. 2008 Jan 18;121(3):632-8.e2.Full text Abstract
37. Motosue MS, Bellolio MF, Van Houten HK, et al. Risk factors for severe anaphylaxis in the United States. Ann Allergy Asthma Immunol. 2017 Oct;119(4):356-1.e2. Abstract
38. LoVerde D, Iweala OI, Eginli A, et al. Anaphylaxis. Chest. 2017 Aug 8;153(2):528-43.Full text Abstract
39. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics. 2000 Oct;106(4):762-6. Abstract
40. Macdougall CF, Cant AJ, Colver AF. How dangerous is food allergy in childhood? The incidence of severe and fatal allergic reactions across the UK and Ireland. Arch Dis Child. 2002 Apr;86(4):236-9.Full text Abstract
41. Toraason M, Sussman G, Biagini R, et al. Latex allergy in the workplace. Toxicol Sci. 2000 Nov;58(1):5-14.Full text Abstract
42. Ausili E, Tabacco F, Focarelli B, et al. Prevalence of latex allergy in spina bifida: genetic and environmental risk factors. Eur Rev Med Pharmacol Sci. 2007 May-Jun;11(3):149-53. Abstract
43. Ricci G, Gentili A, Di Lorenzo F, et al. Latex allergy in subjects who had undergone multiple surgical procedures for bladder exstrophy: relationship with clinical intervention and atopic diseases. BJU Int. 1999 Dec;84(9):1058-62. Abstract
44. Garcia-Larsen V, Ierodiakonou D, Jarrold K, et al. Diet during pregnancy and infancy and risk of allergic or autoimmune disease: a systematic review and meta-analysis. PLoS Med. 2018 Feb 28;15(2):e1002507.Full text Abstract
45. Foong RX, Brough HA, Chan S, et al. US guidelines for the prevention of peanut allergy 2017. Arch Dis Child Educ Pract Ed. 2017 Nov 24;103(5):249-52.Full text Abstract
46. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol. 2005 Sep;95(3):217-26; quiz 226, 258. Abstract
47. Douglas DM, Sukenick E, Andrade WP, et al. Biphasic systemic anaphylaxis: an inpatient and outpatient study. J Allergy Clin Immunol. 1994 Jun;93(6):977-85. Abstract
48. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. J Allergy Clin Immunol. 1986 Jul;78(1 Pt 1):76-83. Abstract
49. Vanden Hoek TL, Morrison LJ, Shuster M, et al. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Part 12.2: cardiac arrest associated with anaphylaxis. Circulation. 2010;122(suppl 3):S829-861.Full text
50. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005 Aug;5(4):359-64. Abstract
51. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004 Aug;114(2):371-6. Abstract
52. Brown SG, Blackman KE, Stenlake V, et al. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J. 2004 Mar;21(2):149-54.Full text Abstract
53. Simons FE, Ardusso LR, Bilò MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):389-99. Abstract
54. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
55. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
56. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006 Aug;26(3):451-63. Abstract
57. Simons FE, Frew AJ, Ansotegui IJ, et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol. 2007 Jul;120(1 suppl):S2-24. Abstract
58. Kaliner M, Dyer J, Merlin S. Increased urine histamine and contrast media reactions. Invest Radiol. 1984 Mar-Apr;19(2):116-8. Abstract
59. Sampson HA, Ho DG. Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol. 1997 Oct;100(4):444-51. Abstract
60. Rentzos G, Lundberg V, Lundqvist C, et al. Use of a basophil activation test as a complementary diagnostic tool in the diagnosis of severe peanut allergy in adults. Clin Transl Allergy. 2015 Jun 11;5:22.Full text Abstract
61. Wang J, Sampson HA. Food anaphylaxis. Clin Exp Allergy. 2007 May;37(5):651-60. Abstract
62. Boyce JA. Successful treatment of cold-induced urticaria/anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006 Jun;117(6):1415-8. Abstract
63. Alangari AA, Twarog FJ, Shih MC, et al. Clinical features and anaphylaxis in children with cold urticaria. Pediatrics. 2004 Apr;113(4):e313-7. Abstract
64. Lefèbvre PR, Cordonnier M, Baleriaux D, et al. An unusual cause of visual loss: involvement of bilateral lateral geniculate bodies. AJNR Am J Neuroradiol. 2004 Oct;25(9):1544-8.Full text Abstract
65. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. December 2011 [internet publication].Full text
66. Hamilton RG, Williams PB, Specific IgE Testing Task Force of the American Academy of Allergy, Asthma & Immunology., et al. Human IgE antibody serology: a primer for the practicing North American allergist/immunologist. J Allergy Clin Immunol. 2010 May 7;126(1):33-8.Full text Abstract
67. Okudaira H, Ito K, Miyamoto T, et al. Evaluation of new system for the detection of IgE antibodies (CAP) in atopic diseases [in Japanese]. Arerugi. 1991 May;40(5):544-54. Abstract
68. Oppenheimer J, Nelson HS. Skin testing. Ann Allergy Asthma Immunol. 2006 Feb;96(2 Suppl 1):S6-12. Abstract
69. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects. J Allergy Clin Immunol. 2007 Jun;119(6):1462-9. Abstract
70. Simons FE. Anaphylaxis. J Allergy Clin Immunol. 2010 Feb;125(2 suppl 2):S161-81.Full text Abstract
71. Golden DB, Demain J, Freeman T, et al. Stinging insect hypersensitivity: a practice parameter update 2016. Ann Allergy Asthma Immunol. 2017 Jan;118(1):28-54. Abstract
72. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis: a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015 Nov;115(5):341-84. Abstract
73. National Institute of Allergy and Infectious Disease (NIAID). Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010 Dec;126(6 suppl):S1-58.Full text Abstract
74. Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008 Mar;100(3 suppl 3):S1-148. Abstract
75. National Institute for Health and Care Excellence. Anaphylaxis: assessment and referral after emergency treatment. 24 August 2020 [internet publication].Full text
76. Perkins GD, Graesner JT, Semeraro F, et al. European Resuscitation Council guidelines 2021: Executive summary. Resuscitation. 2021 Apr;161:1-60.Full text
77. National Institute for Health and Care Excellence. Food allergy in under 19s: assessment and diagnosis. February 2011 [internet publication].Full text
78. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021 Apr;161:115-51.Full text Abstract
79. Colquhoun MC, Handley AJ, Evans TR. ABC of resuscitation. 5th ed. London: BMJ Publishing Group; 2004.
80. Chrimes N, Higgs A, Hagberg CA, et al. Preventing unrecognised oesophageal intubation: a consensus guideline from the Project for Universal Management of Airways and international airway societies. Anaesthesia. 2022 Dec;77(12):1395-415.Full text Abstract
81. Lieberman P, Kemp SF, Oppenheimer J, et al. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol. 2005 Mar;115(3 suppl 2):S483-523. Abstract
82. Pumphrey RS. Fatal posture in anaphylactic shock. J Allergy Clin Immunol. 2003 Aug;112(2):451-2. Abstract
83. Singletary EM, Charlton NP, Epstein JL, et al; International Liaison Committee on Resuscitation First Aid Task Force. 2015 American Heart Association and American Red Cross guidelines update for first aid. Circulation. 2015 Nov 3;132(18 suppl 2):S574-89.Full text Abstract
84. Dinakar, C. Anaphylaxis in children: current understanding and key issues in diagnosis and treatment. Curr Allergy Asthma Rep. 2012 Dec;12(6):641-9.Full text Abstract
85. Sicherer SH, Simons FE. Epinephrine for first-aid management of anaphylaxis. Pediatrics. 2017 Mar;139(3).Full text Abstract
86. Sheikh A, Simons FE, Barbour V, et al. Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD008935.Full text Abstract
87. Sheikh A, Shehata YA, Brown SG, et al. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2009 Feb;64(2):204-12.Full text Abstract
88. Sheikh A, Shehata YA, Brown-Simon GA, et al. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev. 2008 Oct 8;2008(4):CD006312.Full text Abstract
89. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol. 2001 Nov;108(5):871-3. Abstract
90. Simons FE, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):33-7. Abstract
91. Kemp SF, Lockey RF, Simons FE, et al. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy. 2008 Aug;63(8):1061-70. Abstract
92. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014 Jun 9;69(8):1026-45.Full text Abstract
93. Medicines and Healthcare products Regulatory Agency. Adrenaline auto-injectors: updated advice after European review. August 2017 [internet publication].Full text
94. Wang J, Sicherer SH. Guidance on completing a written allergy and anaphylaxis emergency plan. Pediatrics. 2017 Mar;139(3):e20164005.Full text Abstract
95. Sheikh A, Ten Broek V, Brown SG, et al. H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy. 2007 Aug;62(8):830-7.Full text Abstract
96. Sheikh A, Ten Broek VM, Brown-Simon GA, et al. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev. 2007:(1):CD006160.Full text Abstract
97. Andreae DA, Andreae MH. Should antihistamines be used to treat anaphylaxis? BMJ. 2009 Jul 10;339:b2489. Abstract
98. Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012 Oct 17;(10):CD008838.Full text Abstract
99. Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy. 2014 Jun 9;69(8):1008-25.Full text Abstract
100. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007 Apr;204(4):681-96. Abstract
101. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003 Mar 20;348(12):1123-33.Full text Abstract
103. Reich DL. Monitoring in anesthesia and perioperative care. Cambridge: Cambridge University Press; 2011.
104. Abbott Northwestern Hospital Internal Medicine Residency. Internal jugular central venous line. 2022 [internet publication].Full text
105. Bishop L, Dougherty L, Bodenham A, et al. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007 Aug;29(4):261-78. Abstract
106. Practice guidelines for central venous access 2020: an updated report by the American Society of Anesthesiologists Task Force on Central Venous Access. Anesthesiology. 2020 Jan;132(1):8-43.Full text Abstract
107. Fletcher SJ, Bodenham AR. Safe placement of central venous catheters: where should the tip of the catheter lie? Br J Anaesth. 2000 Aug;85(2):188-91. Abstract
108. Gibson F, Bodenham A. Misplaced central venous catheters: applied anatomy and practical management. Br J Anaesth. 2013 Mar;110(3):333-46.Full text Abstract
109. Schuster M, Nave H, Piepenbrock S, et al. The carina as a landmark in central venous catheter placement. Br J Anaesth. 2000 Aug;85(2):192-4. Abstract
110. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text Abstract
111. Soar J, Böttiger BW, Carli P, et al. European Resuscitation Council Guidelines 2021: Adult advanced life support. Resuscitation. 2021 Apr;161:115-51.Full text Abstract
112. Wood RA. Food allergen immunotherapy: current status and prospects for the future. J Allergy Clin Immunol. 2016 Apr;137(4):973-82.Full text Abstract
113. Wang J, Sampson HA. Food allergy: recent advances in pathophysiology and treatment. Allergy Asthma Immunol Res. 2009 Oct;1(1):19-29.Full text Abstract
114. Kleine-Tebbe JB, Huttegger IJ, Saloga U, et al. Specific immunotherapy (hyposensitization) for IgE-mediated allergic diseases. Allergologie. 2010;33:3-34.
115. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol. 2005 Nov;116(5):1073-9. Abstract
116. Mondoulet L, Dioszeghy V, Ligouis M, et al. Epicutaneous immunotherapy on intact skin using a new delivery system in a murine model of allergy. Clin Exp Allergy. 2010 Apr;40(4):659-67. Abstract
117. Larché M. Peptide immunotherapy for allergic diseases. Allergy. 2007 Mar;62(3):325-31.Full text Abstract
118. Worm M, Patel D, Creticos PS. Cat peptide antigen desensitisation for treating cat allergic rhinoconjunctivitis. Expert Opin Investig Drugs. 2013 Aug 21;22(10):1347-57.Full text Abstract
119. Incorvaia C, Montagni M, Ridolo E. The efficiency of peptide immunotherapy for respiratory allergy. Expert Rev Clin Pharmacol. 2016 Mar 7;9(6):831-7. Abstract
120. Li XM, Srivastava K, Grishin A, et al. Persistent protective effect of heat-killed Escherichia coli producing "engineered", recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol. 2003 Jul;112(1):159-67. Abstract
121. Li XM, Srivastava K, Huleatt JW, et al. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J Immunol. 2003 Mar 15;170(6):3289-95.Full text Abstract
122. Prickett SR, Voskamp AL, Phan T, et al. Ara h 1 CD4+ T cell epitope-based peptides: candidates for a peanut allergy therapeutic. Clin Exp Allergy. 2013 Jun;43(6):684-97.Full text Abstract
123. Pascal M, Konstantinou GN, Masilamani M, et al. In silico prediction of Ara h 2 T cell epitopes in peanut-allergic children. Clin Exp Allergy. 2013 Jan;43(1):116-27. Abstract
124. Tighe H, Takabayashi K, Schwartz D, et al. Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):124-34. Abstract
125. Zhu FG, Kandimalla ER, Yu D, et al. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. J Allergy Clin Immunol. 2007 Jun 20;120(3):631-7.Full text Abstract
126. Chang TW, Wu PC, Hsu CL, et al. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases. Adv Immunol. 2007;93:63-119. Abstract
127. Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003 Mar 13;348(11):986-93.Full text Abstract
128. Ramesh M, Karagic M. New modalities of allergen immunotherapy. Hum Vaccin Immunother. 2018;14(12):2848-63.Full text Abstract
129. Li XM, Srivastava K. Traditional Chinese medicine for the therapy of allergic disorders. Curr Opin Otolaryngol Head Neck Surg. 2006 Jun;14(3):191-6. Abstract
130. Qu C, Srivastava K, Ko J, et al. Induction of tolerance after establishment of peanut allergy by the food allergy herbal formula-2 is associated with up-regulation of interferon-gamma. Clin Exp Allergy. 2007 Jun;37(6):846-55. Abstract
131. Lisann L, Song Y, Wang J, et al. Successful prevention of extremely frequent and severe food anaphylaxis in three children by combined traditional Chinese medicine therapy. Allergy Asthma Clin Immunol. 2014 Dec 20;10(1):66.Full text Abstract
132. Arias K, Baig M, Colangelo M, et al. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. J Allergy Clin Immunol. 2009 Aug;124(2):307-14;e1-2.Full text Abstract
133. Mertes PM, Malinovsky JM, Jouffroy L, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol. 2011;21(6):442-53. Abstract
134. Kastner M, Harada L, Waserman S. Gaps in anaphylaxis management at the level of physicians, patients, and the community: a systematic review of the literature. Allergy. 2010 Apr;65(4):435-44. Abstract
135. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis: a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115:341-384. Abstract
136. Bilò BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol. 2008 Aug;8(4):330-7. Abstract
137. Food and Drug Administration. Letter: Important safety information on the EpiPen® and EpiPen Jr® auto-injectors and their authorized generic versions. 23 March 2020 [internet publication].Full text
Use of this content is subject to our disclaimer